Masoud H. Manjili

Department of Microbiology & Immunology, Virginia Commonwealth University- Massey Cancer Center

Affiliated withVirginia Commonwealth University- Massey Cancer Center

Research Area

Biography

Masoud H. Manjili has not added Biography.
If you are Masoud H. Manjili and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 6	2011

Other Publications

Article	Year
Immunotherapy of cancer using heat shock proteins. Frontiers in bioscience : a journal and virtual library\| PubMed ID: 11779704	2002
Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110. Cancer research\| PubMed ID: 11912148	2002
Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor. Cancer immunology, immunotherapy : CII\| PubMed ID: 12111119	2002
Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100. Cancer research\| PubMed ID: 12750279	2003
HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 14530326	2003
Development of cancer vaccines using autologous and recombinant high molecular weight stress proteins. Methods (San Diego, Calif.)\| PubMed ID: 14624871	2004
Cancer immunotherapy and heat-shock proteins: promises and challenges. Expert opinion on biological therapy\| PubMed ID: 15006730	2004
Heat shock proteins HSP70 and GP96: structural insights. Cancer immunology, immunotherapy : CII\| PubMed ID: 16032399	2006
Heat shock proteins and scavenger receptors: role in adaptive immune responses. Immunological investigations\| PubMed ID: 16136784	2005
HSP110 induces "danger signals" upon interaction with antigen presenting cells and mouse mammary carcinoma. Immunobiology\| PubMed ID: 16164037	2005
Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals". Breast cancer research and treatment\| PubMed ID: 16211331	2006
Chaperoning function of stress protein grp170, a member of the hsp70 superfamily, is responsible for its immunoadjuvant activity. Cancer research\| PubMed ID: 16424054	2006
Immunoadjuvant chaperone, GRP170, induces 'danger signals' upon interaction with dendritic cells. Immunology and cell biology\| PubMed ID: 16519738	2006
Comment on "Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma". Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 16585536	2006
Heat shock proteins as vaccine adjuvants in infections and cancer. Drug discovery today\| PubMed ID: 16713905	2006
HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses. European journal of immunology\| PubMed ID: 17304628	2007
Come forth 1E10 anti-idiotype vaccine: delivering the promise to immunotherapy of small cell lung cancer. Cancer biology & therapy\| PubMed ID: 17426436	2007
Tumor immunoediting and immunosculpting pathways to cancer progression. Seminars in cancer biology\| PubMed ID: 17662614	2007
Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design. Cancer immunology, immunotherapy : CII\| PubMed ID: 18278493	2008
Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors. Cancer research\| PubMed ID: 18381452	2008
Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastas... Breast cancer research and treatment\| PubMed ID: 18425677	2009
Does HER-2/neu antigen loss in metastatic breast tumors occur under immune pressure? International journal of cancer. Journal international du cancer\| PubMed ID: 18566999	2008
Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients. International journal of cancer. Journal international du cancer\| PubMed ID: 18567002	2008
Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells. Cancer immunology, immunotherapy : CII\| PubMed ID: 18979098	2009
Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared... Cancer immunology, immunotherapy : CII\| PubMed ID: 19198835	2009
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer research\| PubMed ID: 19276366	2009
Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice. International immunopharmacology\| PubMed ID: 19336265	2009
IL-7 + IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo. Breast cancer research and treatment\| PubMed ID: 19826947	2010
Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function. Journal of translational medicine\| PubMed ID: 19849846	2009
GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells. Breast cancer research and treatment\| PubMed ID: 19898981	2010
Tumour secreted grp170 chaperones full-length protein substrates and induces an adaptive anti-tumour immune response in vivo. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group\| PubMed ID: 20210603	2010
CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer. Breast cancer research and treatment\| PubMed ID: 20480224	2011
Adoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens. Cancer immunology, immunotherapy : CII\| PubMed ID: 21088965	2011
Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer. The Prostate\| PubMed ID: 21229552	2011
Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure. Journal of translational medicine\| PubMed ID: 21453513	2011
A signature of immune function genes associated with recurrence-free survival in breast cancer patients. Breast cancer research and treatment\| PubMed ID: 21479927	2012
Revisiting cancer immunoediting by understanding cancer immune complexity. The Journal of pathology\| PubMed ID: 21480229	2011
Comment on "Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses". Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 21597038	2011
Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer. The Prostate\| PubMed ID: 21656828	2011
Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transg... Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 21670315	2011
CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome. Human pathology\| PubMed ID: 21835433	2012
An immunologic portrait of cancer. Journal of translational medicine\| PubMed ID: 21875439	2011
Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity. Cancer research\| PubMed ID: 21914786	2011
Distinct signatures of the immune responses in low risk versus high risk neuroblastoma. Journal of translational medicine\| PubMed ID: 21978632	2011
Favorable Outcomes in Patients with High Donor-Derived T Cell Count after inÂ Vivo TÂ Cell-Depleted Reduced-Intensity Allogeneic Stem CellÂ Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 22005648	2011
Suppression of antigen-specific CD4(+) T cell activation by SRA/CD204 through reducing the immunostimulatory capability of antigen-presenting cell. Journal of molecular medicine (Berlin, Germany)\| PubMed ID: 22083206	2011